MannKind Corp. (MNKD)
5.98
+0.17
(+2.93%)
USD |
NASDAQ |
Dec 12, 11:32
MannKind Research and Development Expense (TTM): 49.90M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.954B |
| Ocugen, Inc. | 35.49M |
| Protagonist Therapeutics, Inc. | 147.84M |
| Ovid Therapeutics, Inc. | 24.66M |
| Moderna, Inc. | 3.271B |